Skip to main content

Table 2 Patterns of the in situ distribution of PGs in HNSCC lesions (% of cases)

From: Proteoglycan-based diversification of disease outcome in head and neck cancer patients identifies NG2/CSPG4 and syndecan-2 as unique relapse and overall survival predicting factors

PG

Tumor cell positivity1

Overall staining intensity2

Subcellular localization3

Stromal expression

GPC1

-

(27.5)

-

(27.6)

Membrane

-

-

(92.0)

 

+

(29.2)

+

(33.1)

Cytoplasmic

-

+

(6.7)

 

++

(33.1)

++

(30.1)

Both

(72.4)

++

(0.6)

 

+++

(7.4)

+++

(6.7)

  

+++

(0.6)

 

++++

(2.5)

++++

(2.5)

  

++++

-

GPC3

-

(81.6)

-

(81.6)

Membrane

-

-

(100.0)

 

+

(14.1)

+

(14.1)

Cytoplasmic

-

+

-

 

++

(3.1)

++

(4.3)

Both

(18.4)

++

-

 

+++

(1.2)

+++

-

  

+++

-

 

++++

-

++++

-

  

++++

-

GPC4

-

(58.9)

-

(59.5)

Membrane

-

-

(81.0)

 

+

(20.9)

+

(14.1)

Cytoplasmic

(40.5)

+

(5.5)

 

++

(19.0)

++

(25.8)

Both

-

++

(12.9)

 

+++

(1.2)

+++

(0.6)

  

+++

(0.6)

 

++++

-

++++

-

  

++++

-

GPC6

-

(62.2)

-

(62.6)

Membrane

-

-

(90.2)

 

+

(30.1)

+

(31.9)

Cytoplasmic

(37.4)

+

(9.8)

 

++

(7.4)

++

(5.5)

Both

-

++

-

 

+++

-

+++

-

  

+++

-

 

++++

-

++++

-

  

++++

-

SDC1

-

(8.6)

-

(8.6)

Membrane

(42.9)

-

(79.1)

 

+

(31.3)

+

(25.8)

Cytoplasmic

(37.4)

+

(9.2)

 

++

(33.7)

++

(50.3)

Both

(10.4)

++

(10.4)

 

+++

(22.1)

+++

(10.4)

  

+++

(1.2)

 

++++

(4.3)

++++

(4.9)

  

++++

-

SDC2

-

(88.3)

-

(88.3)

Membrane

(1.8)

-

(26.4)

 

+

(6.7)

+

(8.0)

Cytoplasmic

(8.6)

+

(20.2)

 

++

(4.3)

++

(3.1)

Both

-

++

(25.8)

 

+++

(0.6)

+++

(0.6)

  

+++

(21.5)

 

++++

-

++++

-

  

++++

(6.1)

SDC3

-

(65.0)

-

(65.0)

Membrane

-

-

(100.0)

 

+

(27.0)

+

(28.2)

Cytoplasmic

-

+

-

 

++

(6.1)

++

(6.7)

Both

(34.4)

++

-

 

+++

(1.8)

+++

-

  

+++

-

 

++++

-

++++

-

  

++++

-

SDC4

-

(80.4)

-

(80.4)

Membrane

-

-

(100.0)

 

+

(16.0)

+

(19.6)

Cytoplasmic

-

+

-

 

++

(3.7)

++

-

Both

(17.8)

++

-

 

+++

-

+++

-

  

+++

-

 

++++

-

++++

-

  

++++

-

NG2/CSPG4

-

(34.2)

-

(34.2)

Membrane

(62.6)

-

(96.7)

 

+

(38.8)

+

(36.8)

Cytoplasmic

-

+

(3.3)

 

++

(21.7)

++

(19.7)

Both

-

++

-

 

+++

(2.6)

+++

(7.2)

  

+++

-

 

++++

(2.6)

++++

(2.0)

  

++++

-

  1. 1PG expression was assessed semi-quantitatively according to the arbitrary scoring: “-”, no positively staining cells were detected; “+”, <10% of cells were positive; “++”, ≥10% and <50% of positive cells; “+++”, ≥50% and <90% of positive cells; “++++”, ≥90% of positive cells;
  2. 2Refers to the average staining intensity within the examined lesion, according to the arbitrary scoring: “-” = absent; “+”, faint; “++”, weak; “+++”, moderate; “++++”, strong;
  3. 3Immunostaining was prevalently cell membrane-associated (“Membrane”) or diffuse cytoplasmatic (“Cytoplasmic”).